Tagged with P

Luye Pharma What was the transition like from academia into entrepreneurship and what challenges did you face in beginning this company? I realized during this period in the late 1980s that there were no local Chinese companies doing what I wanted to do at the time so I saw there was an…

Knop Chile The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing main milestones and achievements of the company since you have been at the head? My father first began importing homeopathic products and phytomedicines from France, Germany and England in 1920. He continued to study alternative…

China Pharmaceutical Enterprises Association First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent to a state in the US. I worked in a company’s pharmaceutical factory for twenty years holding various positions such as technology director, factory head,…

Fountain Medical Development You have an MD and you’ve worked in industry, but then you decided to become and entrepreneur. What challenges did you face in transitioning to starting your own company and in growing your organization? Entrepreneurship is nothing new in China. Half the population of this country seems to want to…

Venturepharm Venturepharm is the most diversified company we’ve seen, throughout many verticals, taking a full-service plus model from venture capital, merchant banking, CRO, CMO, CSO, compound partnering to royalty sharing. That’s quite broad; what exactly is Venturepharm? The company is centred around our flagship CRO/CMO/CSO, and our positioning is similar to…

China MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps in the country. You just arrived in China in February. The country managers we’ve met have all been here for…

Medicilon/MPI Preclinical Research Shanghai You completed your higher education in the US and worked there for a period afterwards; what caused you to move back to China and start this company? A lot of people are now returning to China after gaining extensive experience in the US. I personally enjoyed the vast experience that…

COFEPRIS It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge was to familiarize myself with the new agency, which has very wide powers as it regulates many industries. COFEPRIS regulates…

Pharma Investi Chile As the President of ASILFA what would you say are the main drivers and challenges for the Chilean pharmaceutical industry today? Chile today is moving to implement a new healthcare system. The government is trying to address the inefficiencies of the public system today and to modernize it so that…

R&D-based Pharmaceutical Association Committe You have a long experience in the Chinese pharmaceutical market, and in particular you saw it evolve tremendously over the last 10 years. From a management perspective, would you say that it is easier or harder to tackle today or a decade ago? In my view, the Chinese market is…

PMG Pharma How has your previous professional experience enriched you to run PMG today? And what would you say have been the main milestones and achievements of PMG Pharma since its creation? I should start by mentioning that my professional background starts with a long term experience in a multinational company –…

Merck Sharp & Dohme Chile What have been MSD’s major milestones and achievements since your establishment in Chile in 1995? We have recently gone through a global merger with Schering Plough, which occurred exactly a year ago. With this in mind, the first milestone that I can mention is the integration of these two relatively…